Filing metadata

Accession number
0001104659-21-092102
Form type
Form 3
Filer
Akero Therapeutics, Inc.
CIK
CIK 1744659
Filed
Jul 14, 2021
Reporting period
Jul 12, 2021
Description
Initial ownership

Explore SEC Filings Hub